TY  - GEN
AU  - Elkind-Hirsch,Karen E
AU  - Paterson,Martha S
AU  - Seidemann,Ericka L
AU  - Gutowski,Hanh C
TI  - Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study
SN  - 1556-5653
PY  - 2017///0714
KW  - Adamantane
KW  - administration & dosage
KW  - Adiposity
KW  - drug effects
KW  - Adolescent
KW  - Adult
KW  - Androgens
KW  - blood
KW  - Biomarkers
KW  - Blood Glucose
KW  - Delayed-Action Preparations
KW  - Dipeptides
KW  - Dipeptidyl-Peptidase IV Inhibitors
KW  - Drug Administration Schedule
KW  - Drug Combinations
KW  - Female
KW  - Glucose Tolerance Test
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Insulin
KW  - Menstrual Cycle
KW  - Metformin
KW  - Pilot Projects
KW  - Polycystic Ovary Syndrome
KW  - Prediabetic State
KW  - Single-Blind Method
KW  - Time Factors
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.fertnstert.2016.09.023
ER  -